Somnomed Receives FDA Approval For New SMH Biomaterial - Can Now Be Used To Make Dental Sleep Devices In The USA

Leading maker and marketer of dental sleep devices, SomnoMed Limited (A SX: SOM) announced that its Swiss Joint Venture, SMH Biomaterial AG, has received US Food and Drug Administration (FDA) approval for a new polymer, the SMH BFlex soft material. The material can now be used to make dental sleep devices in the USA. More importantly, the company has the opportunity to market the material broadly in the USA to other dental and medical device companies.

More: continued here

Filed under: Sleep / Sleep Disorders on February 7th, 2008